This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Wyeth. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovator Spotlight: Jordi Tarres-Call
Introduction: Jordi Tarres-Call is a notable inventor hailing from Banyoles, Spain. With a focus on advancing medical science, he has made significant contributions in the field of vaccine development. His innovative work in creating effective solutions for avian influenza has brought him recognition within the scientific community.
Latest Patents: Jordi holds a patent for "Multivalent avian influenza vaccines," which presents a vaccine composition designed to prevent or ameliorate infections caused by the Avian Influenza Virus. This patent details a unique formulation containing at least two inactivated strains of avian influenza virus. Each strain is specified to possess a hemagglutinin (HA) total of at least 200 HA per dose, with each strain contributing at least 128 HA per dose. Notably, one strain matches the HA subtype of a challenge virus, while the other presents a differing NA subtype, showcasing the innovative complexity of this vaccine.
Career Highlights: Jordi is associated with Wyeth, a company renowned for its significant contributions to pharmaceuticals and vaccines. His patent not only reflects his dedication to combating viral infections but also embodies the potential for advancing public health measures through innovative vaccine technology.
Collaborations: Throughout his career, Jordi has worked closely with esteemed colleagues, including Juan Plana-Duran and Rut Vila-Quintana. Their combined expertise and collaborative spirit have been pivotal in pushing the boundaries of vaccine research and development.
Conclusion: Jordi Tarres-Call's innovative approach to vaccine development exemplifies the vital role of inventors in addressing global health challenges. His work on multivalent avian influenza vaccines is a testament to the impact of research and collaboration in the field of medical science. As developments in vaccine technology continue to evolve, his contributions will likely play a significant role in safeguarding public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile